BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28834216)

  • 1. Beyond the M-CSF receptor - novel therapeutic targets in tumor-associated macrophages.
    Bonelli S; Geeraerts X; Bolli E; Keirsse J; Kiss M; Pombo Antunes AR; Van Damme H; De Vlaminck K; Movahedi K; Laoui D; Raes G; Van Ginderachter JA
    FEBS J; 2018 Feb; 285(4):777-787. PubMed ID: 28834216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined GM-CSF treatment and M-CSF inhibition of tumor-associated macrophages induces dendritic cell-like signaling in vitro.
    Kitoh Y; Saio M; Gotoh N; Umemura N; Nonaka K; Bai J; Vizkeleti L; Torocsik D; Balazs M; Adany R; Takami T
    Int J Oncol; 2011 May; 38(5):1409-19. PubMed ID: 21373754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment.
    Van Overmeire E; Stijlemans B; Heymann F; Keirsse J; Morias Y; Elkrim Y; Brys L; Abels C; Lahmar Q; Ergen C; Vereecke L; Tacke F; De Baetselier P; Van Ginderachter JA; Laoui D
    Cancer Res; 2016 Jan; 76(1):35-42. PubMed ID: 26573801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice.
    Aharinejad S; Paulus P; Sioud M; Hofmann M; Zins K; Schäfer R; Stanley ER; Abraham D
    Cancer Res; 2004 Aug; 64(15):5378-84. PubMed ID: 15289345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models.
    Peng X; Hou P; Chen Y; Dai Y; Ji Y; Shen Y; Su Y; Liu B; Wang Y; Sun D; Jiang Y; Zha C; Xie Z; Ding J; Geng M; Ai J
    J Exp Clin Cancer Res; 2019 Aug; 38(1):372. PubMed ID: 31438996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colony-Stimulating Factor 1 Receptor Blockade Inhibits Tumor Growth by Altering the Polarization of Tumor-Associated Macrophages in Hepatocellular Carcinoma.
    Ao JY; Zhu XD; Chai ZT; Cai H; Zhang YY; Zhang KZ; Kong LQ; Zhang N; Ye BG; Ma DN; Sun HC
    Mol Cancer Ther; 2017 Aug; 16(8):1544-1554. PubMed ID: 28572167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
    Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
    Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Relationship between Tumor-Associated Macrophages and Macrophage Colony-Stimulating Factor as Contributors to Cancer Progression.
    Laoui D; Van Overmeire E; De Baetselier P; Van Ginderachter JA; Raes G
    Front Immunol; 2014; 5():489. PubMed ID: 25339957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The possible mechanisms of tumor progression via CSF-1/CSF-1R pathway activation.
    Huang L; Xu X; Hao Y
    Rom J Morphol Embryol; 2014; 55(2 Suppl):501-6. PubMed ID: 25178319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of CD40 Agonism and CSF-1R Blockade Reconditions Tumor-Associated Macrophages and Drives Potent Antitumor Immunity.
    Wiehagen KR; Girgis NM; Yamada DH; Smith AA; Chan SR; Grewal IS; Quigley M; Verona RI
    Cancer Immunol Res; 2017 Dec; 5(12):1109-1121. PubMed ID: 29097420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization.
    Stafford JH; Hirai T; Deng L; Chernikova SB; Urata K; West BL; Brown JM
    Neuro Oncol; 2016 Jun; 18(6):797-806. PubMed ID: 26538619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diverse in vivo effects of soluble and membrane-bound M-CSF on tumor-associated macrophages in lymphoma xenograft model.
    Liao J; Feng W; Wang R; Ma S; Wang L; Yang X; Yang F; Lin Y; Ren Q; Zheng G
    Oncotarget; 2016 Jan; 7(2):1354-66. PubMed ID: 26595525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-4 enhances murine bone marrow macrophage M-CSF receptor expression by a posttranscriptional mechanism.
    Gibbons R; Ross FP; Perkins SL; Lacey DL; Martin J; Ebner R; Teitelbaum SL; Kahn AJ
    Lymphokine Cytokine Res; 1994 Apr; 13(2):85-92. PubMed ID: 8061119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of GM-CSF and M-CSF on tumor progression of lung cancer: roles of MEK1/ERK and AKT/PKB pathways.
    Uemura Y; Kobayashi M; Nakata H; Kubota T; Bandobashi K; Saito T; Taguchi H
    Int J Mol Med; 2006 Aug; 18(2):365-73. PubMed ID: 16820947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The promotion of breast cancer metastasis caused by inhibition of CSF-1R/CSF-1 signaling is blocked by targeting the G-CSF receptor.
    Swierczak A; Cook AD; Lenzo JC; Restall CM; Doherty JP; Anderson RL; Hamilton JA
    Cancer Immunol Res; 2014 Aug; 2(8):765-76. PubMed ID: 25005824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relative number of macrophages/microglia expressing macrophage colony-stimulating factor and its receptor decreases in multiple sclerosis lesions.
    Werner K; Bitsch A; Bunkowski S; Hemmerlein B; Brück W
    Glia; 2002 Oct; 40(1):121-9. PubMed ID: 12237849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane-bound macrophage colony-stimulating factor and its receptor play adhesion molecule-like roles in leukemic cells.
    Zheng G; Rao Q; Wu K; He Z; Geng Y
    Leuk Res; 2000 May; 24(5):375-83. PubMed ID: 10785259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF-1 regulation of the wandering macrophage: complexity in action.
    Pixley FJ; Stanley ER
    Trends Cell Biol; 2004 Nov; 14(11):628-38. PubMed ID: 15519852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-34 and M-CSF form a novel heteromeric cytokine and regulate the M-CSF receptor activation and localization.
    Ségaliny AI; Brion R; Brulin B; Maillasson M; Charrier C; Téletchéa S; Heymann D
    Cytokine; 2015 Dec; 76(2):170-181. PubMed ID: 26095744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy.
    Li M; Li M; Yang Y; Liu Y; Xie H; Yu Q; Tian L; Tang X; Ren K; Li J; Zhang Z; He Q
    J Control Release; 2020 May; 321():23-35. PubMed ID: 32035193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.